May 03, 2011, 01.10 PM IST
Artillegenc Bio Mar '11 sales at Rs 2.45 crore
Artillegence Bio Innovations has reported a sales turnover of Rs 2.45 crore and a net loss of Rs 0.03 crore for the quarter ended Mar '11
Like this story, share it with millions of investors on M3
Artillegenc Bio Mar '11 sales at Rs 2.45 crore
Artillegence Bio Innovations has reported a sales turnover of Rs 2.45 crore and a net loss of Rs 0.03 crore for the quarter ended Mar '11
Like this story, share it with millions of investors on M3
Artillegenc Bio Mar '11 sales at Rs 2.45 crore
Artillegence Bio Innovations has reported a sales turnover of Rs 2.45 crore and a net loss of Rs 0.03 crore for the quarter ended Mar '11
Share .
Email .
Print .
A+A-
Artillegence Bio Innovations has reported a sales turnover of Rs 2.45 crore and a net loss of Rs 0.03 crore for the quarter ended Mar '11.
| For the quarter ended Mar 2010 the sales turnover was Rs 1.24 crore and net loss was Rs 0.02 crore.
|
|
| | Quarterly Results of Artillegence Bio Innovations | -------- in Rs. Cr. -------- |
|
| Mar '10 | | | Dec '10 | Mar '11 | | Sales Turnover | 1.24 | | | 1.02 | 2.45 | | Other Income | -- | | | -- | -- | | Total Income | 1.24 | | | 1.02 | 2.45 | | Total Expenses | 1.27 | | | 1.02 | 2.48 | | Operating Profit | -0.03 | | | 0.00 | -0.03 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | -0.03 | | | 0.00 | -0.03 | | Interest | -- | | | -- | -- | | PBDT | -0.02 | | | 0.01 | -0.03 | | Depreciation | -- | | | -- | -- | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | -0.02 | | | 0.01 | -0.03 | | Tax | -- | | | -- | -- | | Net Profit | -0.02 | | | 0.01 | -0.03 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | -- | | | 0.01 | -- | | Book Value | -- | | | -- | -- | | Equity | 7.32 | | | 7.32 | 7.32 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 10.00 | 10.00 | | Source : Religare Technova |
|
